Epigenetic alterations of testicular germ cell tumours

被引：7

作者：

Ilijazi, Dafina ^{[1
]}

Shariat, Shahrok F. ^{[1
,2
,3
,4
,5
]}

Hassler, Melanie R. ^{[1
]}

Lemberger, Ursula ^{[1
]}

Ertl, Iris E. ^{[1
]}

机构：

[1] Med Univ Vienna, Ctr Comprehens Canc, Dept Urol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria

[2] Weill Cornell Med Coll, Dept Urol, New York, NY USA

[3] Univ Texas Southwestern, Dept Urol, Dallas, TX USA

[4] Charles Univ Prague, Fac Med 2, Dept Urol, Prague, Czech Republic

[5] IM Sechenov First Moscow State Med Univ, Inst Urol & Reprod Hlth, Moscow, Russia

来源：

CURRENT OPINION IN UROLOGY | 2020年 / 30卷 / 02期

关键词：

DNA methylation; epigenetics; microRNAs; nonseminoma; seminoma; NEOPLASIA IN-SITU; SERUM-LEVELS; PROMOTER METHYLATION; EXPRESSION; BIOMARKER; CHEMOTHERAPY; ONCOGENES; APOPTOSIS; PATTERNS; GROWTH;

D O I：

10.1097/MOU.0000000000000724

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Purpose of review Testicular germ cell tumours (TGCTs) exhibit, in contrast to other cancer types, a relatively low mutational burden. However, numerous epigenetic alterations have been shown to impact TGCT. In this review, we summarize the most relevant findings of the past 2 years. Recent findings Recent studies focused on the functions of microRNAs and the impact of aberrant DNA methylation. Moreover, several epigenetic drugs with antineoplastic effects in TGCTs were identified. Aberrant DNA methylation and differentially expressed microRNAs have an important effect on TGCT pathogenesis. Moreover, differential DNA methylation patterns were found to be specific for different TGCT subtypes. Various microRNAs, such as miR-371a-3p, were found to be highly sensitive and specific biomarkers for TGCT. The epigenetic drugs guadecitabine, animacroxam, and JQ1 showed promising effects on TGCT in preclinical in-vivo and in-vitro studies.

引用

页码：264 / 270

页数：7

共 50 条

[1] Epigenetic profile of testicular germ cell tumours
Okamoto, Keisei
Kawakami, Takahiro
INTERNATIONAL JOURNAL OF ANDROLOGY, 2007, 30 (04): : 385 - 392
[2] Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of 'epidrugs'
Cardoso, Ana Rita
Lobo, Joao
Miranda-Goncalves, Vera
Henrique, Rui
Jeronimo, Carmen
EPIGENETICS, 2021, 16 (04) : 353 - 372
[3] Epigenetic features of testicular germ cell tumours in relation to epigenetic characteristics of foetal germ cells
Kristensen, Dina G.
Skakkebaek, Niels E.
Meyts, Ewa Rajpert-De
Almstrup, Kristian
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2013, 57 (2-4): : 309 - 317
[4] Epigenetic drugs and their molecular targets in testicular germ cell tumours
Jostes, Sina
Nettersheim, Daniel
Schorle, Hubert
NATURE REVIEWS UROLOGY, 2019, 16 (04) : 245 - 259
[5] Epigenetic profile of testicular germ cell tumours - Panel discussion
Looijenga, L.
Okamoto, K.
Meyts, E. Rajpert-De
INTERNATIONAL JOURNAL OF ANDROLOGY, 2007, 30 (04): : 392 - 392
[6] Epigenetic drugs and their molecular targets in testicular germ cell tumours
Sina Jostes
Daniel Nettersheim
Hubert Schorle
Nature Reviews Urology, 2019, 16 : 245 - 259
[7] Testicular germ cell tumours
Horwich, Alan
Nicol, David
Huddart, Robert
BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
[8] Testicular germ cell tumours
Rajpert-De Meyts, Ewa
McGlynn, Katherine A.
Okamoto, Keisei
Jewett, Michael A. S.
Bokemeyer, Carsten
LANCET, 2016, 387 (10029): : 1762 - 1774
[9] The genetics of testicular germ cell tumours
Rapley, EA
Crockford, GP
Easton, DF
Stratton, MR
Bishop, DT
GERM CELL TUMOURS V, 2002, : 3 - 22
[10] Imaging and testicular germ cell tumours
Hubert, J
Descotes, JL
Martin, B
PROGRES EN UROLOGIE, 2003, 13 (05): : 969 - 984

← 1 2 3 4 5 →